In a recent pilot study, researchers investigated the influence that particular diets and the gut microbiome have on Alzheimer disease markers and mild cognitive impairment.
New data presented at the Alzheimer’s Association International Conference indicate that measuring levels of this biomarker in plasma and cerebrospinal fluid can detect Alzheimer disease with high...
In a study of nearly 1.5 million people, researchers aimed to determine the impact of infections on the risk of mortality among people with or without dementia. The findings were presented at the...
Influenza vaccination may be a “promising, readily available candidate” for the prevention of Alzheimer disease, according to new findings presented at the Alzheimer’s Association International Conference.
...
Data from 3 studies presented at the 2020 Alzheimer’s Association International Conference suggest that vaccination against influenza and pneumonia is associated with a reduction in the risk of Alzheimer...
Despite known, independent associations of hearing loss and vision loss with dementia, less is known about the relationship between dual sensory impairment and dementia risk. Researchers aimed to assess...
The FDA has granted a landmark approval to an intravenous injection for the imaging of tau pathology among patients with cognitive impairment being evaluated for Alzheimer disease.
After reviewing data from 4500 MESA participants, researchers determined whether tracking cross-sectionally measured NT-proBNP over 3.2 years is related to incident dementia. Find out more about this new...
In a new study, investigators evaluated data on more than 31,000 patients to determine whether specific antihypertensive medication classes can reduce the risk of dementia vs other classes.
In a new study, researchers used the largest aggregate of genome-wide association studies data to identify novel risk loci and gained further insight into the causes of Parkinson disease.
